Screener
Harvard Bioscience HBIO Q4 2025 Annual earnings
Reported March 12, 2026 · Before market open
Revenue$23.7MBeat by $635.0K
EPS-$0.01Miss by $0.36
Revenue estimate$23.1M
EPS estimate$0.35
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$21.8M
EPS estimate-$0.17
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Harvard Bioscience report Q4 2025 earnings?
- Harvard Bioscience (HBIO) reported Q4 2025 earnings on March 12, 2026 before market open.
- What were Harvard Bioscience's Q4 2025 revenue and EPS?
- Harvard Bioscience reported revenue of $23.7M and eps of $-0.01 for Q4 2025.
- Did Harvard Bioscience beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $23.1M by $635.0K. EPS missed the consensus estimate of $0.35 by $0.36.
- How did Harvard Bioscience's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 3.3% from $24.6M a year earlier.
- Where can I find Harvard Bioscience's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001171843-26-001447) and the 10-K periodic report (0001171843-26-001548) directly on SEC EDGAR. The filing index links above go to sec.gov.
